GLPBio

CGP 42112

Catalog No.: GC15406Purity:>99.00%Synonyms: CGP42112A
CGP 42112 (CGP 42112A) هو ناهض قوي لمستقبلات الأنجيوتنسين II من النوع الفرعي 2 (AT2 R).

المنتجات مخصصة للاستخدام البحثي فقط، وليست للاستخدام البشري. نحن لا نبيع للمرضى.


CGP 42112
Cas No.: 127060-75-7
10mM (in 1mL DMSO)In Stock
$496.00
1
1mgIn Stock
$70.00
1
5mgIn Stock
$262.00
1

المراجع (Citations)

لا تتوفر حاليًا مراجع لهذا المنتج. فيما يلي مجموعة مختارة من المنشورات التي تستشهد بمنتجات GlpBio.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

الوصف (Description)

CGP 42112 is an effective angiotensin II subtype 2 receptor (AT2R) agonist [1]. AT2R plays a crucial role in the development of the kidney and exerts anti-proliferative, anti-fibrotic and pro-apoptotic effects in vivo [2]. CGP 42112 can be used for studies on isolated rat hearts and vascular endothelial function [3].

In vitro, treatment of NR8383 cells with CGP 42112 (2nM) for 6-24 hours can weaken the effect of lipopolysaccharide (LPS) on the cells, significantly reduce the expression of M1 polarization markers (including iNOS and TNF-α), and inhibit the expression of p-p65, p50, p-ERK1/2 and p-IκBα [4]. CGP 42112 (0.1-100μM) treated the renal proximal tubule suspension (1mg/ml) at 37°C for 30 minutes can inhibit NKA activity in a dose-dependent manner and increase the accumulation of cGMP in the proximal tubules [5].

In vivo, CGP 42112 (5, 10 and 20μg/kg, once every 3 days, total three times) administered by intra-articular injection to rats can significantly reduce the arthritis index of a single left hind paw. CGP 42112 can improve the histological signs of arthritis rats [6]. CGP 42112 (1mg/kg; once; i.p.) administered to ATla-deficient mice has no effect on the plasma aldosterone and corticosterone levels of the mice [7].

References:
[1] Takekoshi K, Ishii K, Isobe K, et al. Angiotensin-II subtype 2 receptor agonist (CGP-42112) inhibits catecholamine biosynthesis in cultured porcine adrenal medullary chromaffin cells[J]. Biochemical and Biophysical Research Communications, 2000, 272(2): 544-550.
[2] Elbaz N, Bedecs K, Masson M, et al. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor[J]. Molecular Endocrinology, 2000, 14(6): 795-804.
[3] Raffai G, Durand M J, Lombard J H. Acute and chronic angiotensin-(1–7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats[J]. American Journal of Physiology-Heart and Circulatory Physiology, 2011, 301(4): H1341-H1352. 
[4] Zheng X, Xu Z, Xu L, et al. Angiotensin II Type 2 receptor inhibits M1 polarization and apoptosis of alveolar macrophage and protects against mechanical ventilation-induced lung injury[J]. Inflammation, 2025, 48(1): 165-180. 
[5] Hakam A C, Hussain T. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway[J]. American Journal of Physiology-Renal Physiology, 2006, 290(6): F1430-F1436.
[6] Wang D, Hu S, Zhu J, et al. Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant‐induced arthritis[J]. Journal of cellular and molecular medicine, 2013, 17(12): 1577-1587. 
[7] Naruse M, Tanabe A, Sugaya T, et al. Deferential roles of angiotensin receptor subtypes in adrenocortical function in mice[J]. Life sciences, 1998, 63(18): 1593-1598.

البروتوكول (Protocol)

Cell experiment [1]:

Cell lines

NR8383 cells

Preparation Method

Rat alveolar macrophages (NR8383) were cultured in F12K medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. Cells were seeded on 6-well plates at a density of 4 × 106 cells/ml for Western blot, PCR and flow cytometry experiments. After 24h incubation, the cells were stimulated with DMSO medium, LPS (100ng/mL) 、AT2R activator CGP 42112 (2nM) 、AT2R inhibitor PD123319 (70nM) and AT1R inhibitor valsartan (100μM, CGP 48933) for 6h or 24h. In addition, the cells were mounted onto slides for fluorescent immunohistochemistry.

Reaction Conditions

2nM; 6h, 24h

Applications

The AT2R agonist CGP 42112 can weaken the effect of LPS, significantly reducing the expression of M1 polarization markers (including iNOS and TNF-α), and simultaneously inhibiting the expressions of p-p65, p50, p-ERK1/2 and p-IκBα.
Animal experiment [2]:

Animal models

Sprague-Dawley rats

Preparation Method

Adjuvant-induced arthritis (AIA) rats were randomly assigned to the following treatments: losartan (5, 10 and 15mg/kg/day, orally, once daily), MTX (0.5mg/kg, intraperitoneally, per 3 days), and vehicle (NS). Sham-operated rats received the vehicle (NS). The treatment started on day 14 after immunization and continued until day 28. After 15 days of treatment, on day 28, all rats were anesthetized with the chloral hydrate and killed (n = 6 per group). The serum, paw and spleen were collected for further study. To study the effects of AT2R agonist on rats with AIA, CGP 42112 (5, 10 and 20μg/kg, once every 3 days, total three times) and triamcinolone acetonide (1mg/kg, once every 3 days, total three times) were administered by intra-articular injection into the left hind (non-injected) paws following the onset of the secondary arthritis (n = 7 per group). Normal and model rats received NS instead.

Dosage form

5, 10 and 20μg/kg, once every 3 days, total three times; intra-articular injection

Applications

Intra-articular injection of AIA rats with CGP 42112 (10 and 20μg/kg) significantly decreased the arthritis index of single left hind (non-injected) paw on days 22 and 26.

References:
[1]Zheng X, Xu Z, Xu L, et al. Angiotensin II Type 2 receptor inhibits M1 polarization and apoptosis of alveolar macrophage and protects against mechanical ventilation-induced lung injury[J]. Inflammation, 2025, 48(1): 165-180. 
[2] Wang D, Hu S, Zhu J, et al. Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant?induced arthritis[J]. Journal of cellular and molecular medicine, 2013, 17(12): 1577-1587.

وثائق المنتج (Product Documents)

Purity:>99.00%Appearance:A solid

الخصائص الكيميائية (Chemical Properties)

رقم CAS
127060-75-7
المرادفات
CGP42112A
الصيغة الجزيئية
C52H69N13O11
الوزن الجزيئي
1052.2
الذوبانية
DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 30 mg/ml,PBS (pH 7.2): 10 mg/ml
التخزين
Desiccate at -20°C
إرشادات عامة
اختر مذيبًا مناسبًا وفقًا لبيانات ذوبانية المنتج. بعد التحضير، قسّم المحلول المخزون إلى أجزاء لتجنب دورات التجميد والذوبان المتكررة.
استخدم المحاليل المخزونة خلال 6 أشهر عند حفظها في -80°C، أو خلال شهر واحد عند حفظها في -20°C.
لتحسين الذوبانية، سخّن الأنبوب إلى 37°C وعرّضه للموجات فوق الصوتية لمدة مناسبة.
شروط الشحن
تُشحن عينات التقييم مع عبوات تبريد. وتُشحن الأحجام الأخرى المتاحة في درجة حرارة الغرفة، أو مع عبوات تبريد عند الطلب.

الحاسبات (Calculators)المولارية / التخفيف / الوزن الجزيئي / تحويل الوحدات / تركيبة داخل الجسم الحي / الذوبانية

g/mol

Reviews

Review for CGP 42112

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%